RECURRENT GLIOBLASTOMA IDH WILDTYPE
Clinical trials for RECURRENT GLIOBLASTOMA IDH WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA IDH WILDTYPE trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA IDH WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Direct-to-Brain attack: new combo targets deadly recurrent tumor
Disease control Recruiting nowThis early-stage study is testing the safety and effectiveness of a two-part immunotherapy for adults whose aggressive brain cancer (glioblastoma) has returned after initial treatment. After surgery to remove the main tumor, a special combination of two drugs is delivered directl…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
Experimental cell therapy targets deadly recurrent brain cancer
Disease control Recruiting nowThis study is testing an experimental cell therapy called P134 for adults whose aggressive brain cancer (glioblastoma) has come back. Doctors will give patients modified immune cells (CAR-T cells) designed to target the tumor and see if it is safe and can help control the cancer.…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
Fat cells fight brain cancer: new stem cell trial offers hope
Disease control Recruiting nowThis early-stage trial is testing whether stem cells from donated body fat can be safely injected into the brain during surgery to treat aggressive brain cancer that has returned. The study aims to find the safest dose and see if these cells can slow tumor growth and improve surv…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Drug-Radiation combo tested for aggressive brain cancers that return
Disease control Recruiting nowThis early-stage trial is testing whether combining an experimental drug called triapine with radiation therapy is safe for adults with glioblastoma or astrocytoma brain tumors that have returned after previous treatment. The study aims to find the highest dose of triapine that c…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Double-Punch immunotherapy trial aims to extend life for deadly brain cancer patients
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs before and after surgery can help people with glioblastoma that has returned after initial treatment. The trial will enroll 54 adults whose brain cancer has come back despite previous surgery, radiation, and chemotherap…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC